To expand our sample size, we performed a meta-analysis using a previously published surrogate dataset; specifically, we examined posttreatment ALT measurements in almost 100 volunteers experiencing a first-in-life infection as part of a human challenge study (Reuling et al., 2018). The gene discussed is GPT; the disease is infection.